AsymBio

AsymBio, a division of the Asymchem Group, is committed to being the CDMO partner of choice to global pharmaceutical companies of all sizes, providing R&D and manufacturing solutions throughout the entire lifecycle of innovative drug development. AsymBio delivers efficient, customizable, and extensive, high-quality services to clients. Their personalized services offer comprehensive capabilities covering process development, product manufacturing, fill-finish, analytical development and testing, domestic and overseas regulatory registration, and submission filings for a broad range of novel biopharmaceuticals, including antibodies, recombinant biotherapeutics, bioconjugates, plasmids, and mRNAs.